UPDATE: JPMorgan Starts Mirum Pharamceuticals (MIRM) at Overweight
Tweet Send to a Friend
(Updated - September 20, 2021 4:47 AM EDT)
JPMorgan analyst Jessica Fye initiates coverage on Mirum Pharamceuticals (NASDAQ: MIRM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Jessica Fye initiates coverage on Mirum Pharamceuticals (NASDAQ: MIRM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
